{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:36:02Z","timestamp":1774524962614,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,29]]},"DOI":"10.7759\/cureus.39671","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T05:25:14Z","timestamp":1685424314000},"source":"Crossref","is-referenced-by-count":1,"title":["Serological Response to COVID-19 and Its Association With Measles-Rubella (MR)-Containing Vaccines"],"prefix":"10.7759","author":[{"given":"Jahnavi","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafat S","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shukla","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Gomber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100741","article-title":"Exploring the causes of mild COVID-19 involvement in pediatric patients","volume":"37","author":"Naserghandi A","year":"2020","unstructured":"Naserghandi A, Saffarpour R, Allameh SF. Exploring the causes of mild COVID-19 involvement in pediatric patients. New Microbes New Infect. 2020, 37:100741. 10.1016\/j.nmni.2020.100741","journal-title":"New Microbes New Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1960161","article-title":"Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2","volume":"20","author":"Sharma D","year":"2021","unstructured":"Sharma D. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2. Expert Rev Vaccines. 2021, 20:1051-7. 10.1080\/14760584.2021.1960161","journal-title":"Expert Rev Vaccines"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1773141","article-title":"Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?","volume":"16","author":"Anbarasu A","year":"2020","unstructured":"Anbarasu A, Ramaiah S, Livingstone P. Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?. Hum Vaccin Immunother. 2020, 16:2217-8. 10.1080\/21645515.2020.1773141","journal-title":"Hum Vaccin Immunother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00120","article-title":"Does early childhood vaccination protect against COVID-19?","volume":"7","author":"Sidiq KR","year":"2020","unstructured":"Sidiq KR, Sabir DK, Ali SM, Kodzius R. Does early childhood vaccination protect against COVID-19?. Front Mol Biosci. 2020, 7:120. 10.3389\/fmolb.2020.00120","journal-title":"Front Mol Biosci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7003.481","article-title":"Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries","volume":"311","author":"Aaby P","year":"1995","unstructured":"Aaby P, Samb B, Simondon F, Seck AM, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ. 1995, 311:481-5. 10.1136\/bmj.311.7003.481","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.43","article-title":"Harnessing the beneficial heterologous effects of vaccination","volume":"16","author":"Goodridge HS","year":"2016","unstructured":"Goodridge HS, Ahmed SS, Curtis N, et al.. Harnessing the beneficial heterologous effects of vaccination. Nat Rev Immunol. 2016, 16:392-400. 10.1038\/nri.2016.43","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina MJ","year":"2015","unstructured":"Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015, 348:694-9. 10.1126\/science.aaa3662","journal-title":"Science"},{"key":"ref8","unstructured":"Immunization coverage. (2022). Accessed. February 14, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.10.003","article-title":"MMR vaccination: a potential strategy to reduce severity and mortality of COVID-19 illness","volume":"134","author":"Ashford JW","year":"2021","unstructured":"Ashford JW, Gold JE, Huenergardt MA, et al.. MMR vaccination: a potential strategy to reduce severity and mortality of COVID-19 illness. Am J Med. 2021, 134:153-5. 10.1016\/j.amjmed.2020.10.003","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/all.14584","article-title":"Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: all mild course","volume":"76","author":"Larenas-Linnemann DE","year":"2021","unstructured":"Larenas-Linnemann DE, Rodr\u00edguez-Monroy F. Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: all mild course. Allergy. 2021, 76:910-4. 10.1111\/all.14584","journal-title":"Allergy"},{"key":"ref11","unstructured":"Guidelines for management of COVID-19 in children (18th June, 2021). (2021). Accessed. February 12, 2023: https:\/\/www.mohfw.gov.in\/pdf\/GuidelinesforManagementofCOVID19inCHILDREN18June2021final.pdf.."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/00368504221105172","article-title":"Revisiting the potential role of BCG and MMR vaccines in COVID-19","volume":"105","author":"Bayram Z","year":"2022","unstructured":"Bayram Z, Musharrafieh U, Bizri AR. Revisiting the potential role of BCG and MMR vaccines in COVID-19. Sci Prog. 2022, 105:368504221105172. 10.1177\/00368504221105172","journal-title":"Sci Prog"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.22034\/iji.2021.87990.1843","article-title":"Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?","volume":"18","author":"Hassani D","year":"2021","unstructured":"Hassani D, Amiri MM, Maghsood F, et al.. Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?. Iran J Immunol. 2021, 18:47-53. 10.22034\/iji.2021.87990.1843","journal-title":"Iran J Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241471","article-title":"Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2","volume":"15","author":"Kandeil A","year":"2020","unstructured":"Kandeil A, Gomaa MR, El Taweel A, et al.. Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS One. 2020, 15:e0241471. 10.1371\/journal.pone.0241471","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.06.045","article-title":"Recent MMR vaccination in health care workers and Covid-19: a test negative case-control study","volume":"39","author":"Lundberg L","year":"2021","unstructured":"Lundberg L, Bygdell M, Stukat von Feilitzen G, Woxenius S, Ohlsson C, Kindblom JM, Leach S. Recent MMR vaccination in health care workers and Covid-19: a test negative case-control study. Vaccine. 2021, 39:4414-8. 10.1016\/j.vaccine.2021.06.045","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1930471","article-title":"A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children","volume":"17","author":"Gujar N","year":"2021","unstructured":"Gujar N, Tambe M, Parande M, et al.. A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children. Hum Vaccin Immunother. 2021, 17:3316-21. 10.1080\/21645515.2021.1930471","journal-title":"Hum Vaccin Immunother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3201\/eid2709.211042","article-title":"Predictors of nonseroconversion after SARS-CoV-2 infection","volume":"27","author":"Liu W","year":"2021","unstructured":"Liu W, Russell RM, Bibollet-Ruche F, et al.. Predictors of nonseroconversion after SARS-CoV-2 infection. Emerg Infect Dis. 2021, 27:2454-8. 10.3201\/eid2709.211042","journal-title":"Emerg Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/158703-serological-response-to-covid-19-and-its-association-with-measles-rubella-mr-containing-vaccines","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:19Z","timestamp":1707508999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/158703-serological-response-to-covid-19-and-its-association-with-measles-rubella-mr-containing-vaccines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.39671","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,29]]}}}